Skip to main content

Table 2 Univariable analysis of disease-free and overall survival in gastric cancer

From: Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer

   Disease-free suivival Overall survival
Characteristic No. HR 95%CI p HR 95%CI p
Age(y)     .343    .583
< 60 95 1.00    1.00   
≥60 86 0.834 0.573-1.214   0.898 0.611-1.320  
Sex     .662    .950
Male 129 1.00    1.00   
Female 52 0.909 0.591-1.396   0.986 0.639-1.521  
Tumor size     .151    .232
≤4 cm 63 1.00    1.00   
> 4 cm 118 1.345 0.897-2.016   1.287 0.851-1.945  
pT stage     .001    .005
pT1 17 1.00    1.00   
pT2 35 1.549 0.558-4.301 .401 1.535 0.553-4.264 .411
pT3 119 3.546 1.437-8.750 .006 3.237 1.310-8.001 .011
pT4 10 4.738 1.547-14.506 .006 4.068 1.289-12.836 .017
pN stage     < .0001    .001
Negative 44 1.00    1.00   
Positive 137 2.617 1.538-4.451   2.389 1.401-4.075  
pTNM stage     < .0001    .001
I 26 1.00    1.00   
II 47 2.920 1.197-7.121 .018 2.860 1.173-6.973 .021
III 100 4.955 2.152-11.409 < .0001 4.455 1.930-10.281 < .0001
IV 8 7.369 2.470-21.981 < .0001 6.103 1.965-18.957 .002
p-mTOR     .008    .013
Negative 88 1.00    1.00   
Positive 93 1.667 1.146-2.454   1.644 1.112-2.430